Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when OHI files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Departure of CEO (new) — CEO C. Taylor Pickett departing effective October 1, 2026.
- Departure of CFO (new) — CFO Robert O. Stephenson departing effective August 1, 2026.
Omega Healthcare announces CEO and CFO departures in planned leadership transition
Filed May 21, 2026 · Period ending May 19, 2026 · ~1 min read
Key Changes
-
high
CEO C. Taylor Pickett departing October 1, 2026; President Matthew Gourmand (age 51, with company since 2017) promoted to CEO. Described as planned retirement and succession.
Item 5.02 verify on EDGAR → -
high
CFO Robert Stephenson departing August 1, 2026; Senior VP and Chief Accounting Officer Neal Ballew (age 40, with company since 2020) promoted to CFO.
Item 5.02 verify on EDGAR → -
medium
Departing CEO receives un-prorated 2026 bonus, equity vesting through December 2029, 18 months COBRA coverage, and $20,000/month consulting through October 2027 (extendable to April 2028).
Item 5.02 verify on EDGAR → -
medium
Departing CFO receives severance per employment agreement, un-prorated 2026 bonus, equity vesting through December 2029, and $12,000/month consulting through August 2027 (extendable to February 2028).
Item 5.02 verify on EDGAR → -
medium
Incoming CEO Gourmand brings background as equity portfolio manager at Millennium Partners and Stevens Capital, equity research analyst at UBS, and auditor at Deloitte (CPA/CA).
Item 5.02 verify on EDGAR →
Summary
Omega Healthcare Investors announced a planned leadership transition with both its CEO and CFO departing in 2026. CEO C. Taylor Pickett will leave October 1st, with President Matthew Gourmand taking over. CFO Robert Stephenson departs August 1st, succeeded by Chief Accounting Officer Neal Ballew. The company frames these as planned retirements and long-term succession moves, with both successors promoted from within.
For retail investors, simultaneous departures of top executives always warrant attention, even when described as planned. The company is promoting internal candidates with institutional knowledge—Gourmand has been with Omega since 2017 and Ballew since 2020—which suggests continuity.
Both departing executives receive generous severance including un-prorated bonuses and extended equity vesting through 2029, plus consulting arrangements lasting over a year. Watch for: the Q2 and Q3 earnings calls where the new leadership team will present their strategic vision. Also monitor whether the company provides additional context on the timing and any operational changes accompanying the transition.
Section-by-Section Diff
Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation
CEO and CFO departures announced with planned October and August 2026 transitions; internal successors appointed.
Added in current filing · verify on EDGAR →
On May 19, 2026, the Board of Directors (the “Board”) of Omega Healthcare Investors, Inc. (the “Company”) approved senior leadership transitions reflecting upcoming retirement plans and the Company’s long-term leadership succession planning. On May 19, 2026, the Board and C. Taylor Pickett, the Company’s Chief Executive Officer, mutually agreed that Mr. Pickett’s employment with the Company and position as a member of the Board will terminate effective October 1, 2026 (the “CEO Transition Date”). The Board also appointed Matthew P. Gourmand, the Company’s President, to serve as the Company’s President and Chief Executive Officer, effective as of the CEO Transition Date.
CEO C. Taylor Pickett will depart effective October 1, 2026, described as part of retirement planning and long-term succession. Matthew P. Gourmand, currently President, will assume the CEO role on that date. Gourmand has been President since January 2025 and previously led Corporate Strategy & Investor Relations since October 2017.
Added in current filing · verify on EDGAR →
on May 19, 2026, the Board and Robert O. Stephenson mutually agreed that Mr. Stephenson’s employment with the Company will terminate effective August 1, 2026 (the “CFO Transition Date”). The Board also appointed Neal A. Ballew, the Company’s Senior Vice President and Chief Accounting Officer, to serve as the Company’s Chief Financial Officer, and Lucas M. Golem, the Company’s Vice President of Financial Reporting, to succeed Mr. Ballew’s position and serve as the Company’s Chief Accounting Officer, both effective as of the CFO Transition Date.
CFO Robert O. Stephenson will depart effective August 1, 2026. Neal A. Ballew, currently Senior VP and Chief Accounting Officer since August 2020, will become CFO. Lucas M. Golem, currently VP of Financial Reporting, will become Chief Accounting Officer. Both transitions occur on the same date.
Added in current filing · verify on EDGAR →
The Pickett Transition Agreement provides that Mr. Pickett will be entitled to receive the annual short-term incentive actually earned for 2026 on an un-prorated basis, his previously granted equity incentives will vest through December 31, 2029 on an un-prorated basis but otherwise subject to the terms of such awards, and he will be entitled to employer-paid group health insurance premiums pursuant to COBRA coverage for up to 18 months following the CEO Transition Date.
Departing CEO Pickett receives un-prorated 2026 annual incentive, equity vesting through December 31, 2029 on an un-prorated basis, and 18 months of employer-paid COBRA health coverage. He will also receive ownership transfer of his supplemental life insurance policy and a consulting arrangement paying $20,000 per month through October 2027, extendable to April 2028.
Added in current filing · verify on EDGAR →
The Stephenson Transition Agreement provides that Mr. Stephenson will be entitled to receive the payments and benefits due in connection with a termination of employment by the Company without cause pursuant to his Employment Agreement effective January 1, 2026, as amended, provided that he will also be entitled to the annual short-term incentive actually earned for 2026 on an un-prorated basis, and his previously granted equity incentives will vest through December 31, 2029 on an un-prorated basis but otherwise subject to the terms of such awards.
Departing CFO Stephenson receives severance per his employment agreement for termination without cause, plus un-prorated 2026 annual incentive and equity vesting through December 31, 2029 on an un-prorated basis. He will also receive ownership transfer of his supplemental life insurance policy and a consulting arrangement paying $12,000 per month through August 2027, extendable to February 2028.
Added in current filing · verify on EDGAR →
Mr. Gourmand (age 51) has served as the Company’s President since January 1, 2025. Prior to that, Mr. Gourmand had served as the Company’s Senior Vice President of Corporate Strategy & Investor Relations since October 2017. Prior to joining the Company, Mr. Gourmand spent ten years as an equity portfolio manager at Millennium Partners and Stevens Capital Management, three years as an equity research analyst at UBS and six years in the audit department of Deloitte, where he qualified as a Chartered Accountant and a Certified Public Accountant.
Incoming CEO Gourmand (age 51) has been with the company since October 2017, most recently as President since January 2025. He brings experience as an equity portfolio manager, equity research analyst at UBS, and auditor at Deloitte. Incoming CFO Ballew (age 40) has been Senior VP and Chief Accounting Officer since August 2020, previously spending a decade at Ernst & Young in real estate audit practice.
Event · Item 7.01 — Regulation FD Disclosure
Company announced executive transitions via press release furnished as Exhibit 99.1.
Added in current filing · verify on EDGAR →
On May 21, 2026, the Company issued a press release announcing the executive transitions described above.
The company disclosed executive transitions through a press release on May 21, 2026. The specific details of which executives are transitioning and their roles are referenced as 'described above' but not included in this Item 7.01 excerpt. This is a Regulation FD disclosure, meaning the information is being publicly released to ensure fair disclosure to all investors simultaneously.
Event · Item 9.01 — Financial Statements and Exhibits
Omega Healthcare disclosed transition and consulting agreements with Pickett and Stephenson, effective later in 2026.
Added in current filing · verify on EDGAR →
Transition Agreement and Release, dated as of May 19, 2026, among Omega Healthcare Investors, Inc., OHI Asset Management LLC and Mr. Pickett. 10.2 Consulting Agreement, dated as of May 19, 2026, and effective as of October 2, 2026, between Omega Healthcare Investors, Inc. and Mr. Pickett.
The company entered into a transition agreement and release with Mr. Pickett on May 19, 2026, along with a consulting agreement that becomes effective October 2, 2026. These agreements typically accompany executive departures or role changes, where the executive transitions out of their current position and may provide consulting services for a period afterward.
Added in current filing · verify on EDGAR →
Transition Agreement and Release, dated as of May 19, 2026, among Omega Healthcare Investors, Inc., OHI Asset Management LLC and Mr. Stephenson. 10.4 Consulting Agreement, dated as of May 19, 2026, and effective as of August 2, 2026, between Omega Healthcare Investors, Inc. and Mr. Stephenson.
The company entered into a transition agreement and release with Mr. Stephenson on May 19, 2026, along with a consulting agreement that becomes effective August 2, 2026. Similar to the Pickett agreements, these documents suggest Mr. Stephenson is transitioning out of his current role while maintaining a consulting relationship with the company.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 8, 2026 · How we verify